BE779144A - Derives de benzodiazepines et leur preparation - Google Patents

Derives de benzodiazepines et leur preparation

Info

Publication number
BE779144A
BE779144A BE779144A BE779144A BE779144A BE 779144 A BE779144 A BE 779144A BE 779144 A BE779144 A BE 779144A BE 779144 A BE779144 A BE 779144A BE 779144 A BE779144 A BE 779144A
Authority
BE
Belgium
Prior art keywords
preparation
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Application number
BE779144A
Other languages
English (en)
French (fr)
Inventor
J B Hester
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BE779144A publication Critical patent/BE779144A/xx
Priority claimed from US00372313A external-priority patent/US3856792A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE779144A 1971-02-09 1972-02-09 Derives de benzodiazepines et leur preparation BE779144A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11404971A 1971-02-09 1971-02-09
US24075672A 1972-04-03 1972-04-03
US00372313A US3856792A (en) 1971-02-09 1973-06-21 2-{8 2-(substituted aminomethyl)-4h-1,2,4-triazol-4-yl{9 benzophenones

Publications (1)

Publication Number Publication Date
BE779144A true BE779144A (fr) 1972-08-09

Family

ID=27381433

Family Applications (1)

Application Number Title Priority Date Filing Date
BE779144A BE779144A (fr) 1971-02-09 1972-02-09 Derives de benzodiazepines et leur preparation

Country Status (14)

Country Link
US (1) US3709898A (pt)
JP (1) JPS4966679A (pt)
BE (1) BE779144A (pt)
BR (1) BR7200590D0 (pt)
CA (1) CA966123A (pt)
CH (2) CH570404A5 (pt)
DE (2) DE2265617C3 (pt)
DK (1) DK513578A (pt)
FR (1) FR2124559B1 (pt)
GB (4) GB1374823A (pt)
HK (1) HK2580A (pt)
NL (1) NL151709B (pt)
SE (1) SE414928B (pt)
ZA (1) ZA7251B (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE397831B (sv) * 1971-06-05 1977-11-21 Takeda Chemical Industries Ltd Sett att framstella s-triazolo-(4,3-a)(1,4)bensodiazepinderivat
US3904641A (en) * 1971-06-18 1975-09-09 Yoshitomi Pharmaceutical Triazolothienodiazepine compounds
BE790838A (fr) * 1971-11-02 1973-04-30 Upjohn Co Nouvelles 1-aminophenyl-6-phenyl-s-triazolo (4,3-a) (1,4)- benzodiazepines, leur procede de preparation et medicament les contenant
US3842090A (en) * 1973-02-14 1974-10-15 Upjohn Co Certain 1-aminomethyl-6-phenyl 4h-s-triazolo(4,3-a)(1,4)benzodiazepines
CA999000A (en) * 1973-02-14 1976-10-26 Jackson B. Hester (Jr.) Process for new benzodiazepines and intermediates
US3879413A (en) * 1973-02-14 1975-04-22 Upjohn Co Process for the production of 6-phenyl-4-H-s-triazolo {8 4,3-a{9 {8 1,4{9 benzodiazepines
US4263310A (en) * 1974-03-02 1981-04-21 Boehringer Ingelheim Gmbh 8-Bromo-6-(o-chloro-phenyl)-4H-S-triazolo-[3,4,-c]-thieno-[2,3-e]-1,4-diazepines and salts thereof
GB1517164A (en) * 1974-08-20 1978-07-12 Roche Products Ltd Substituted-phenyl ketones and a process for the manufacture thereof
US4000151A (en) * 1974-09-11 1976-12-28 The Upjohn Company Triazolyl benzophenone compounds
US4000153A (en) * 1974-09-26 1976-12-28 The Upjohn Company Triazolobenzodiazepine intermediates
NL7512983A (nl) * 1974-11-06 1976-05-10 Parke Davis & Co Werkwijze voor het bereiden van diazepineverbin- dingen, werkwijze voor het bereiden van een far- maceutisch preparaat met toepassing daarvan als- mede een zo gevormd preparaat.
CH601267A5 (pt) * 1975-12-12 1978-06-30 Ciba Geigy Ag
US4105851A (en) * 1975-09-08 1978-08-08 Parke, Davis & Company 1,3,8-Trimethylimidazopyrazolodiazepine compounds
US4009175A (en) * 1976-03-15 1977-02-22 The Upjohn Company 1-[(Aminooxy)-methyl]-6-substituted-4H-s-triazolo[4,3-a][1,4] benzodiazepines
US4405518A (en) * 1981-07-23 1983-09-20 Hoffmann-La Roche Inc. Pyrrolo[3,4-d] [2] benzazepines
US4409390A (en) * 1981-07-23 1983-10-11 Hoffmann-La Roche Inc. Pyrrolo[3,4-D][2]Benzazepines
US4375473A (en) * 1982-01-04 1983-03-01 The Upjohn Company Method
US4501698A (en) * 1983-03-31 1985-02-26 The Upjohn Company Preparing 1-(hydroxymethyl)-triazolobenzodiazepines and 1-(aminomethyl)-triazolobenzodiazepines
MX354217B (es) 2010-05-14 2018-02-19 Dana Farber Cancer Inst Inc Composiciones y metodos para el tratamiento de leucemia.
CN103180318B (zh) 2010-05-14 2017-05-10 达那-法伯癌症研究所 雄性避孕组合物以及使用方法
BR122014024883A2 (pt) * 2010-05-14 2019-08-20 Dana-Farber Cancer Institute, Inc. Compostos no tratamento de neoplasia
AU2015201727B2 (en) * 2010-05-14 2018-03-08 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
WO2012151512A2 (en) 2011-05-04 2012-11-08 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2721031B1 (en) 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
WO2015013635A2 (en) 2013-07-25 2015-01-29 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
RU2016122654A (ru) 2013-11-08 2017-12-14 Дана-Фарбер Кэнсер Инститьют, Инк. Комбинированная терапия злокачественной опухоли с использованием ингибиторов бромодоменового и экстратерминального (вет) белка
EP3099677A4 (en) 2014-01-31 2017-07-26 Dana-Farber Cancer Institute, Inc. Diaminopyrimidine benzenesulfone derivatives and uses thereof
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
CN106456653A (zh) 2014-02-28 2017-02-22 腾沙治疗公司 高胰岛素血症相关病症的治疗
US9969747B2 (en) 2014-06-20 2018-05-15 Constellation Pharmaceuticals, Inc. Crystalline forms of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide
CA2955077A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Dihydropteridinone derivatives and uses thereof
BR112017002369A2 (pt) 2014-08-08 2017-12-05 Dana Farber Cancer Inst Inc derivados de diazepana e usos dos mesmos
EA033325B1 (ru) 2014-10-27 2019-09-30 Тэнша Терапеутикс, Инк. Ингибиторы бромодомена
WO2016201370A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
WO2017044792A1 (en) 2015-09-11 2017-03-16 Dana-Farber Cancer Institute, Inc. Acetamide thienotriazoldiazepines and uses thereof
BR112018004618A2 (pt) 2015-09-11 2018-09-25 Dana-Farber Cancer Institute, Inc. ciano tienotriazoldiazepinas e usos das mesmas
SG10201913450PA (en) 2015-11-25 2020-03-30 Dana Farber Cancer Inst Inc Bivalent bromodomain inhibitors and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413346A (en) * 1966-01-19 1968-11-26 Hoffmann La Roche 2-(2-haloethylamino)-5-halo-benzophenones
US3987052A (en) * 1969-03-17 1976-10-19 The Upjohn Company 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
DE1955349C2 (de) * 1969-11-04 1982-01-28 Takeda Chemical Industries, Ltd., Osaka s-Triazolo [4,3-a] [1,4] benzodiazepine
YU34997B (en) * 1970-03-27 1980-06-30 Hiroyuki Tawada Process for preparing benzodiazepine derivatives

Also Published As

Publication number Publication date
BR7200590D0 (pt) 1973-07-17
DE2203782A1 (de) 1972-08-24
GB1374822A (en) 1974-11-20
GB1374823A (en) 1974-11-20
NL7201692A (pt) 1972-08-11
SE414928B (sv) 1980-08-25
GB1374825A (en) 1974-11-20
NL151709B (nl) 1976-12-15
JPS4966679A (pt) 1974-06-27
FR2124559B1 (pt) 1975-08-01
DE2265617C3 (de) 1982-05-06
DE2265617B2 (de) 1981-07-16
CA966123A (en) 1975-04-15
ZA7251B (en) 1972-09-27
CH569736A5 (pt) 1975-11-28
DK513578A (da) 1978-11-17
US3709898A (en) 1973-01-09
HK2580A (en) 1980-01-25
FR2124559A1 (pt) 1972-09-22
AU3772572A (en) 1973-07-12
GB1374824A (en) 1974-11-20
DE2203782C2 (de) 1982-05-13
CH570404A5 (pt) 1975-12-15

Similar Documents

Publication Publication Date Title
BE779144A (fr) Derives de benzodiazepines et leur preparation
BE813356A (fr) Penicillines et leur preparation
BE795907A (fr) 2-amino-4-arylthiazoles 5-substitues et leur preparation
BE783440A (fr) Derives de benzofuranne et leur preparation
BE817546A (fr) Derives antibiotiques et leur preparation
BE798677A (fr) Derives de benzodiazepine, leur preparation et leurs applications
BE797101A (fr) Chlorothiazoles et leur preparation
BE793629A (fr) Nouveaux derives de benzodiazepines et leur preparation
BE787251A (fr) Nouvelles benzodiazepines et leur preparation
BE815497A (fr) Derives de triazolo-isoindole et leur preparation
BE797705R (fr) Derives de benzodiazepines et leur preparation
BE785024A (fr) Derives de 2-nitro-5-imidazolaldehyde et leur
BE786133A (fr) Extraits de houblon et leur preparation
BE782680A (fr) Nouvelles benzodiazepines substituees et leur
BE798752A (fr) Derives de 4-oxyde de pyrazine et leur preparation
BE786529A (fr) Nouveaux derives de la diazepine et procedes pour leur preparation
BE829829A (fr) Nouveaux derives de benzodiazepines et leur preparation
BE807097A (fr) Derives de la piperidinesulfonyluree et leur preparation
BE760233R (fr) Derives de lincomycines et leur
BE794100A (fr) Derives 3-hydrazonomethyles de rifamycine et leur preparation
BE798957A (fr) Nouveaux derives de triamcinolone et leur preparation
BE801310A (fr) Derives de diphenylmethane et leur preparation
BE774061A (fr) Nouveaux derives de la benzodiazepine et leur
BE795881A (fr) Tribromopyrazoles et leur preparation
BE792207A (fr) Nouveaux derives de benzodiazepine et leur preparation

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: THE UPJOHN CY

Effective date: 19920209